Paper98317
Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy.
Chapman AG and 2 others. Epilepsia, 1978. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Papers, record 98317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/98317
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticonvulsants | Major topic |
| Benzodiazepinones | Major topic |
| Seizures | Major topic |
| Acoustic Stimulation | |
| Animals | |
| Disease Models, Animal | |
| Drug Evaluation, Preclinical | |
| Electroencephalography | |
| Epilepsies, Partial | |
| Epilepsy | |
| Glycine | |
| Haplorhini | |
| Mice | |
| Papio | |
| Photic Stimulation |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,734,774 | Synergistic seizure reduction in patient with persistently elevated N-desmethylclobazam levels, CYP450 genetic polymorphism, and responsive neurostimulator targeting centromedian nuclei of bilateral thalami. | Epilepsy Behav Rep | 2025 | https://conductscience.org/library/papers/40734774 | PubMed |
| 26,089,675 | Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome. | Ther Clin Risk Manag | 2015 | https://conductscience.org/library/papers/26089675 | PubMed |
| 23,683,707 | Molecular mechanisms of antiseizure drug activity at GABAA receptors. | Seizure | 2013 | https://conductscience.org/library/papers/23683707 | PubMed |
| 22,145,708 | GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. | CNS Drugs | 2012 | https://conductscience.org/library/papers/22145708 | PubMed |
| 17,199,029 | Clobazam. | Neurotherapeutics | 2007 | https://conductscience.org/library/papers/17199029 | PubMed |
| 6,661,360 | No effect of food intake on clobazam absorption. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661360 | PubMed |
| 6,404,410 | Clobazam as adjunctive treatment in refractory epilepsy. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6404410 | PubMed |
| 6,107,238 | Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. | Drugs | 1980 | https://conductscience.org/library/papers/6107238 | PubMed |
| 108,705 | Anticonvulsant activity in photosensitive baboons, Papio papio, of two new 1,5 benzodiazepines. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/108705 | PubMed |
| 35,206 | Clobazam: anticonvulsant action in animal models of epilepsy [proceedings]. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/35206 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/98317
GET https://conductscience.org/api/papers/v1/98317/authors